Nnamdi Etoh
Rock Springs Capital Management Lp
Assets Managed
$1.697B
Holdings
100
Last Quarter
2026 - Q1
Filed Date
21d ago
Growth Rate
-13%(2Q avg: 0.48%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Rock Springs Capital Management Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 100 positions.
Assets under management
The assets under management (AUM) of Rock Springs Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.697B in assets, with a quarterly growth rate of -13% and a 2-quarter average growth rate of 0.48%. The portfolio is managed by Nnamdi Etoh, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
RVMD Revolution Medicines Inc
| 6.94% | $117.62M 1.209M shares@ $97.25 avg price | Decreased -9.42% |
LLY Eli Lilly & Co
| 5.36% | $90.781M 98,700 shares@ $919.77 avg price | Decreased -6.35% |
MDGL Madrigal Pharmaceuticals Inc
| 5.28% | $89.513M 170,999 shares@ $523.48 avg price | Increased 22.48% |
MIRM Mirum Pharmaceuticals Inc
| 4.42% | $74.947M 811,294 shares@ $92.39 avg price | Increased 6.43% |
ARGX Argenx Se - Adr
| 4.24% | $71.93M 98,500 shares@ $730.25 avg price | Decreased -4.6% |
RYTM Rhythm Pharmaceuticals Inc
| 3.54% | $59.987M 689,748 shares@ $86.98 avg price | Decreased -0.75% |
INSM Insmed Inc
| 3.03% | $51.394M 314,300 shares@ $163.52 avg price | Decreased -1.55% |
ASND Ascendis Pharma A S - Adr
| 2.62% | $44.374M 194,000 shares@ $228.73 avg price | Decreased -4.66% |
XENE Xenon Pharmaceuticals Inc
| 2.62% | $44.37M 763,020 shares@ $58.15 avg price | Decreased -3.14% |
TVTX Travere Therapeutics Inc
| 2.59% | $43.91M 1.478M shares@ $29.71 avg price | Decreased -33.13% |
1-10 of 100